Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report)’s stock price dropped 2.3% during trading on Wednesday. The stock traded as low as C$5.05 and last traded at C$5.07. 25,962 shares changed hands during trading, a decline of 45% from the average daily volume of 47,312 shares. The stock had previously closed at C$5.19.
Medexus Pharmaceuticals Trading Up 1.6%
The stock has a market capitalization of C$160.90 million, a P/E ratio of -73.14 and a beta of 0.54. The business’s fifty day simple moving average is C$5.09 and its two-hundred day simple moving average is C$4.36.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
See Also
- Five stocks we like better than Medexus Pharmaceuticals
- Costco Ends Its Fiscal Year on a High Note, Eyes Big Expansion
- Cracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic Problem
- Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-Out
- Oil May Be Stronger Than It Looks—And Diamondback Is on Sale
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
